Flores, C., Gil, J., Abraham, R., Pham, C., Wildes, T., Moore, G., … Mitchell, D. (2017). IMMU-22. ADOPTIVE CELL THERAPY AGAINST DIPG USING DEVELOPMENTALLY REGULATED ANTIGENS. Neuro-Oncology, 19(suppl_4), iv32–iv32. https://doi.org/10.1093/neuonc/nox083.132

Flores, Catherine, Jorge Gil, Rebecca Abraham, Christina Pham, Tyler Wildes, Ginger Moore, Jeffrey Drake, Kyle Dyson, and Duane Mitchell. “IMMU-22. ADOPTIVE CELL THERAPY AGAINST DIPG USING DEVELOPMENTALLY REGULATED ANTIGENS.” Neuro-Oncology 19, no. suppl_4 (June 2017): iv32–iv32. https://doi.org/10.1093/neuonc/nox083.132.

Flores C, Gil J, Abraham R, Pham C, Wildes T, Moore G, et al. IMMU-22. ADOPTIVE CELL THERAPY AGAINST DIPG USING DEVELOPMENTALLY REGULATED ANTIGENS. Neuro-Oncology. 2017 Jun;19(suppl_4):iv32–iv32.

Flores, Catherine, et al. “IMMU-22. ADOPTIVE CELL THERAPY AGAINST DIPG USING DEVELOPMENTALLY REGULATED ANTIGENS.” Neuro-Oncology, vol. 19, no. suppl_4, Oxford University Press (OUP), June 2017, pp. iv32–iv32. Crossref, doi:10.1093/neuonc/nox083.132.

Flores C, Gil J, Abraham R, Pham C, Wildes T, Moore G, Drake J, Dyson K, Mitchell D. IMMU-22. ADOPTIVE CELL THERAPY AGAINST DIPG USING DEVELOPMENTALLY REGULATED ANTIGENS. Neuro-Oncology. Oxford University Press (OUP); 2017 Jun;19(suppl_4):iv32–iv32.